About: FDA restricts use of erythropoiesis stimulating drugs

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : FDA restricts use of erythropoiesis stimulating drugs Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/bmj/2010/volume_340/issue_2010/w
Subject	Gynecological cancer Urology Medicines regulation news Chronic renal failure Urological surgery Drugs: endocrine system Cervical cancer Immunology (including allergy)
Title	FDA restricts use of erythropoiesis stimulating drugs
has manifestation of work	http://hub.abes.fr/bmj/periodical/bmj/2010/volume_340/issue_2010/B36ED9CE69A20C0CE053120B220A1E16/m/web http://hub.abes.fr/bmj/periodical/bmj/2010/volume_340/issue_2010/B36ED9CE69A20C0CE053120B220A1E16/m/print
related by	http://hub.abes.fr/bmj/periodical/bmj/2010/volume_340/issue_2010/B36ED9CE69A20C0CE053120B220A1E16/authorship/1
article type	news
publisher identifier	epo2702
is part of this journal	British Medical Journal
PubMed ID	20176703

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata